Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer’s disease

BACKGROUND: Late-life onset neuropsychiatric symptoms are established risk factors for dementia. The mild behavioral impairment (MBI) diagnostic framework was designed to standardize assessment to determine dementia risk better. In this Mini Review, we summarize the emerging clinical and biomarker e...

Descripción completa

Detalles Bibliográficos
Autores principales: Creese, Byron, Ismail, Zahinoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Mini Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734161/
https://www.ncbi.nlm.nih.gov/pubmed/34986891
http://dx.doi.org/10.1186/s13195-021-00949-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734161/
https://www.ncbi.nlm.nih.gov/pubmed/34986891
http://dx.doi.org/10.1186/s13195-021-00949-7

Ejemplares similares